These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 34786042)

  • 1.
    Ma T; Meng L; Wang X; Tian Z; Wang J; Liu X; Zhang W; Zhang Y
    Am J Transl Res; 2021; 13(10):11048-11064. PubMed ID: 34786042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive insights on pivotal prognostic signature involved in clear cell renal cell carcinoma microenvironment using the ESTIMATE algorithm.
    Luo J; Xie Y; Zheng Y; Wang C; Qi F; Hu J; Xu Y
    Cancer Med; 2020 Jun; 9(12):4310-4323. PubMed ID: 32311223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SAA1 Has Potential as a Prognostic Biomarker Correlated with Cell Proliferation, Migration, and an Indicator for Immune Infiltration of Tumor Microenvironment in Clear Cell Renal Cell Carcinoma.
    Xu Z; Wu Y; Fu G; Chen X; Sun J; Tian J; Jiang P; Wang Y; Jin B
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IGLL5 is correlated with tumor-infiltrating immune cells in clear cell renal cell carcinoma.
    Xia ZN; Wang XY; Cai LC; Jian WG; Zhang C
    FEBS Open Bio; 2021 Mar; 11(3):898-910. PubMed ID: 33449444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caspase 4 Overexpression as a Prognostic Marker in Clear Cell Renal Cell Carcinoma: A Study Based on the Cancer Genome Atlas Data Mining.
    Meng L; Tian Z; Long X; Diao T; Hu M; Wang M; Zhang W; Zhang Y; Wang J; He Y
    Front Genet; 2020; 11():600248. PubMed ID: 33584797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KCNN4 is a potential prognostic marker and critical factor affecting the immune status of the tumor microenvironment in kidney renal clear cell carcinoma.
    Chen S; Wang C; Su X; Dai X; Li S; Mo Z
    Transl Androl Urol; 2021 Jun; 10(6):2454-2470. PubMed ID: 34295732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MUC20 as a novel prognostic biomarker in ccRCC correlating with tumor immune microenvironment modulation.
    Xue B; Guo WM; Jia JD; Kadeerhan G; Liu HP; Bai T; Shao Y; Wang DW
    Am J Cancer Res; 2022; 12(2):695-712. PubMed ID: 35261796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of genes of prognostic value in the ccRCC microenvironment from TCGA database.
    Wan B; Liu B; Huang Y; Lv C
    Mol Genet Genomic Med; 2020 Apr; 8(4):e1159. PubMed ID: 32012488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microenvironment-associated gene HSD11B1 may serve as a prognostic biomarker in clear cell renal cell carcinoma: a study based on TCGA, RT‑qPCR, Western blotting, and immunohistochemistry.
    Han D; Yu Z; Zhang H; Liu H; Wang B; Qian D
    Bioengineered; 2021 Dec; 12(2):10891-10904. PubMed ID: 34845968
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Meng L; He X; Hong Q; Qiao B; Zhang X; Wu B; Zhang X; Wei Y; Li J; Ye Z; Xiao Y
    Front Oncol; 2021; 11():618187. PubMed ID: 33692955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BTK Has Potential to Be a Prognostic Factor for Lung Adenocarcinoma and an Indicator for Tumor Microenvironment Remodeling: A Study Based on TCGA Data Mining.
    Bi KW; Wei XG; Qin XX; Li B
    Front Oncol; 2020; 10():424. PubMed ID: 32351880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PYCR1 regulates glutamine metabolism to construct an immunosuppressive microenvironment for the progression of clear cell renal cell carcinoma.
    Wei X; Zhang X; Wang S; Wang Y; Ji C; Yao L; Song N
    Am J Cancer Res; 2022; 12(8):3780-3798. PubMed ID: 36119844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophil extracellular traps-associated modification patterns depict the tumor microenvironment, precision immunotherapy, and prognosis of clear cell renal cell carcinoma.
    Teng ZH; Li WC; Li ZC; Wang YX; Han ZW; Zhang YP
    Front Oncol; 2022; 12():1094248. PubMed ID: 36620592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of CCL4 as an Immune-Related Prognostic Biomarker Associated With Tumor Proliferation and the Tumor Microenvironment in Clear Cell Renal Cell Carcinoma.
    Zhang L; Zhang M; Wang L; Li J; Yang T; Shao Q; Liang X; Ma M; Zhang N; Jing M; Song R; Fan J
    Front Oncol; 2021; 11():694664. PubMed ID: 34900664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying endoplasmic reticulum stress-related genes as new diagnostic and prognostic biomarkers in clear cell renal cell carcinoma.
    Yu H; Zhang C; Bai X; Yin H; Li X; Zhou X; He W; Kuang Y; Gou X; Li J
    Transl Androl Urol; 2024 Jan; 13(1):1-24. PubMed ID: 38404554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrative Analysis of Immune-Related Genes in the Tumor Microenvironment of Renal Clear Cell Carcinoma and Renal Papillary Cell Carcinoma.
    Zheng B; Xie F; Cheng F; Wang J; Yao Z; He W; Niu Z
    Front Mol Biosci; 2021; 8():760031. PubMed ID: 34888353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microenvironment-related gene TNFSF13B predicts poor prognosis in kidney renal clear cell carcinoma.
    Jiang M; Lin J; Xing H; An J; Yang J; Wang B; Yu M; Zhu Y
    PeerJ; 2020; 8():e9453. PubMed ID: 32655996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value and immune infiltration of novel signatures in clear cell renal cell carcinoma microenvironment.
    Xu WH; Xu Y; Wang J; Wan FN; Wang HK; Cao DL; Shi GH; Qu YY; Zhang HL; Ye DW
    Aging (Albany NY); 2019 Sep; 11(17):6999-7020. PubMed ID: 31493764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of CXCL13 and Immune Cell Infiltration Signature in Clear Cell Renal Cell Carcinoma.
    Jiao F; Sun H; Yang Q; Sun H; Wang Z; Liu M; Chen J
    Int J Med Sci; 2020; 17(11):1610-1624. PubMed ID: 32669964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel prognostic model based on immunogenomics for clear cell renal cell carcinoma.
    Wu Z; Shen Y; Fan D; Liu J; Chen D; Wang K; Xu X
    Int Immunopharmacol; 2021 Jan; 90():107119. PubMed ID: 33243605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.